Rapid Viral Testing and Antibiotic Prescription in Febrile Children With Respiratory Symptoms Visiting Emergency Departments in Europe.


Journal

The Pediatric infectious disease journal
ISSN: 1532-0987
Titre abrégé: Pediatr Infect Dis J
Pays: United States
ID NLM: 8701858

Informations de publication

Date de publication:
01 01 2022
Historique:
pubmed: 5 12 2021
medline: 20 1 2022
entrez: 4 12 2021
Statut: ppublish

Résumé

Inappropriate antibiotic prescribing often occurs in children with self-limiting respiratory tract infections, contributing to antimicrobial resistance. It has been suggested that rapid viral testing can reduce inappropriate antibiotic prescribing. We aimed to assess the association between rapid viral testing at the Emergency Department (ED) and antibiotic prescription in febrile children. This study is part of the MOFICHE study, which is an observational multicenter study including routine data of febrile children (0-18 years) attending 12 European EDs. In children with respiratory symptoms visiting 6 EDs equipped with rapid viral testing, we performed multivariable logistic regression analysis regarding rapid viral testing and antibiotic prescription adjusted for patient characteristics, disease severity, diagnostic tests, focus of infection, admission, and ED. A rapid viral test was performed in 1061 children (8%) and not performed in 11,463 children. Rapid viral test usage was not associated with antibiotic prescription (aOR 0.9, 95% CI: 0.8-1.1). A positive rapid viral test was associated with less antibiotic prescription compared with children without test performed (aOR 0.6, 95% CI: 0.5-0.8), which remained significant after adjustment for CRP and chest radiograph result. Twenty percent of the positively tested children received antibiotics. A negative rapid viral test was not associated with antibiotic prescription (aOR 1.2, 95% CI: 1.0-1.4). Rapid viral test usage did not reduce overall antibiotic prescription, whereas a positive rapid viral test did reduce antibiotic prescription at the ED. Implementation of rapid viral testing in routine emergency care and compliance to the rapid viral test outcome will reduce inappropriate antibiotic prescribing at the ED.

Sections du résumé

BACKGROUND
Inappropriate antibiotic prescribing often occurs in children with self-limiting respiratory tract infections, contributing to antimicrobial resistance. It has been suggested that rapid viral testing can reduce inappropriate antibiotic prescribing. We aimed to assess the association between rapid viral testing at the Emergency Department (ED) and antibiotic prescription in febrile children.
METHODS
This study is part of the MOFICHE study, which is an observational multicenter study including routine data of febrile children (0-18 years) attending 12 European EDs. In children with respiratory symptoms visiting 6 EDs equipped with rapid viral testing, we performed multivariable logistic regression analysis regarding rapid viral testing and antibiotic prescription adjusted for patient characteristics, disease severity, diagnostic tests, focus of infection, admission, and ED.
RESULTS
A rapid viral test was performed in 1061 children (8%) and not performed in 11,463 children. Rapid viral test usage was not associated with antibiotic prescription (aOR 0.9, 95% CI: 0.8-1.1). A positive rapid viral test was associated with less antibiotic prescription compared with children without test performed (aOR 0.6, 95% CI: 0.5-0.8), which remained significant after adjustment for CRP and chest radiograph result. Twenty percent of the positively tested children received antibiotics. A negative rapid viral test was not associated with antibiotic prescription (aOR 1.2, 95% CI: 1.0-1.4).
CONCLUSIONS
Rapid viral test usage did not reduce overall antibiotic prescription, whereas a positive rapid viral test did reduce antibiotic prescription at the ED. Implementation of rapid viral testing in routine emergency care and compliance to the rapid viral test outcome will reduce inappropriate antibiotic prescribing at the ED.

Identifiants

pubmed: 34862345
doi: 10.1097/INF.0000000000003326
pii: 00006454-202201000-00008
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

39-44

Informations de copyright

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Références

Sands R, Shanmugavadivel D, Stephenson T, et al. Medical problems presenting to paediatric emergency departments: 10 years on. Emerg Med J. 2012;29:379–382.
van de Maat J, van de Voort E, Mintegi S, et al. Antibiotic prescription for febrile children in European emergency departments: a cross-sectional, observational study. Lancet Infect Dis. 2019;19:382–91.
Nair H, Brooks WA, Katz M, et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet. 2011;378:1917–1930.
A Hogan C, Caya C, Papenburg J. Rapid and simple molecular tests for the detection of respiratory syncytial virus: a review. Expert Rev Mol Diagn. 2018;18:617–629.
Black RE, Cousens S, Johnson HL, et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet. 2010;375:1969–87.
Wolfe I, Cass H, Thompson MJ, et al. Improving child health services in the UK: insights from Europe and their implications for the NHS reforms. BMJ. 2011;342:d1277.
World Health Organization. [updated 2017]. Available at: https://www.who.int/gho/child_health/mortality/causes/en/ . Accessed April 2, 2020.
Cough (acute): antimicrobial prescribing: The National Institute for Health and Care excellence 2019. [updated 7 February 2019]. Available at: https://www.nice.org.uk/guidance/ng120 . Accessed April 28, 2020.
World Health Organization. [updated 15 February 2018]. Available at: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance . Accessed April 2, 2020.
Lee JJ, Verbakel JY, Goyder CR, et al. The clinical utility of point-of-care tests for influenza in ambulatory care: a systematic review and meta-analysis. Clin Infect Dis. 2019;69:24–33.
Egilmezer E, Walker GJ, Bakthavathsalam P, et al. Systematic review of the impact of point-of-care testing for influenza on the outcomes of patients with acute respiratory tract infection. Rev Med Virol. 2018;28:e1995.
Li-Kim-Moy J, Dastouri F, Rashid H, et al. Utility of early influenza diagnosis through point-of-care testing in children presenting to an emergency department. J Paediatr Child Health. 2016;52:422–429.
Bronchiolitis in children: diagnosis and management: The National Institue for Health and Care excellence 2015. [updated August 2019]. Available at: https://www.nice.org.uk/guidance/ng9 . Accessed April 30, 2020.
Breakell R, Thorndyke B, Clennett J, et al. Reducing unnecessary chest X-rays, antibiotics and bronchodilators through implementation of the NICE bronchiolitis guideline. Eur J Pediatr. 2018;177:47–51.
Gonzalez MD, McElvania E. New developments in rapid diagnostic testing for children. Infect Dis Clin North Am. 2018;32:19–34.
PERFORM c. Personalised Risk assessment in Febrile illness to Optimise Real-life Management (PERFORM). Available at: https://www.perform2020.org/ . Accessed April 2, 2020.
von Hippel PT. Regression with missing Ys: an improved strategy for analyzing multiply imputed data. Socialogic Methodol. 2007;83:116.
Borensztajn D, Yeung S, Hagedoorn NN, et al. Diversity in the emergency care for febrile children in Europe: a questionnaire study. BMJ Paediatr Open. 2019;3:e000456.
Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–381.
Simon TD, Cawthon ML, Stanford S, et al.; Center of Excellence on Quality of Care Measures for Children with Complex Needs (COE4CCN) Medical Complexity Working Group. Pediatric medical complexity algorithm: a new method to stratify children by medical complexity. Pediatrics. 2014;133:e1647–e1654.
Fever in under 5s: assessment and initial management The Natoinal Institue for Health and Care excellence 2019 [updated 7 November 2019]. Available at: https://www.nice.org.uk/guidance/ng143 . Accessed April 20, 2020.
Turner MT, Leroy PL. Advanced Paediatric Life Support. 5th ed. 2017.
Hagedoorn NN, Borensztajn DM, Nijman R, et al.; PERFORM consortium. Variation in antibiotic prescription rates in febrile children presenting to emergency departments across Europe (MOFICHE): a multicentre observational study. PLoS Med. 2020;17:e1003208.
van Houten CB, Oved K, Eden E, et al. Observational multi-centre, prospective study to characterize novel pathogen-and host-related factors in hospitalized patients with lower respiratory tract infections and/or sepsis - the “TAILORED-Treatment” study. BMC Infect Dis. 2018;18:377.
Herberg JA, Kaforou M, Wright VJ, et al.; IRIS Consortium. Diagnostic test accuracy of a 2-transcript host RNA signature for discriminating bacterial vs viral infection in febrile children. JAMA. 2016;316:835–845.
Doan Q, Enarson P, Kissoon N, et al. Rapid viral diagnosis for acute febrile respiratory illness in children in the Emergency Department. Cochrane Database Syst Rev. 2014;2014:CD006452.
Basile K, Kok J, Dwyer DE. Point-of-care diagnostics for respiratory viral infections. Expert Rev Mol Diagn. 2018;18:75–83.
Bruning AHL, Leeflang MMG, Vos J, et al. Rapid tests for influenza, respiratory syncytial virus, and other respiratory viruses: a systematic review and meta-analysis. Clin Infect Dis. 2017; 65:1026–32.
Spurling GK, Doust J, Del Mar CB, et al. Antibiotics for bronchiolitis in children. Cochrane Database Syst Rev. 2011;6:CD005189.
Zipursky A, Kuppermann N, Finkelstein Y, et al.; PEDIATRIC EMERGENCY RESEARCH NETWORKS (PERN). International practice patterns of antibiotic therapy and laboratory testing in bronchiolitis. Pediatrics. 2020;146:e20193684.
Ouldali N, Bellêttre X, Milcent K, et al. Impact of implementing national guidelines on antibiotic prescriptions for acute respiratory tract infections in pediatric emergency departments: an interrupted time series analysis. Clin Infect Dis. 2017;65:1469–1476.
Levine DA, Platt SL, Dayan PS, et al.; Multicenter RSV-SBI Study Group of the Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections. Pediatrics. 2004;113:1728–1734.
Greenes DS, Harper MB. Low risk of bacteremia in febrile children with recognizable viral syndromes. Pediatr Infect Dis J. 1999;18:258–261.
Smitherman HF, Caviness AC, Macias CG. Retrospective review of serious bacterial infections in infants who are 0 to 36 months of age and have influenza A infection. Pediatrics. 2005;115:710–718.
Krief WI, Levine DA, Platt SL, et al.; Multicenter RSV-SBI Study Group of the Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. Influenza virus infection and the risk of serious bacterial infections in young febrile infants. Pediatrics. 2009;124:30–39.

Auteurs

Chantal D Tan (CD)

From the Department of General Paediatrics, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.

Nienke N Hagedoorn (NN)

From the Department of General Paediatrics, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.

Juan E Dewez (JE)

Faculty of Tropical and Infectious Disease, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Dorine M Borensztajn (DM)

From the Department of General Paediatrics, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.

Ulrich von Both (U)

Division of Paediatric Infectious Diseases, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
German Centre for Infection Research, DZIF, Partner Site Munich, Munich, Germany.

Enitan D Carrol (ED)

Veterinary and Ecological Sciences Liverpool, Institute of Infection, University of Liverpool, Liverpool, United Kingdom.
Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom.

Marieke Emonts (M)

Great North Children's Hospital, Paediatric Immunology, Infectious Diseases & Allergy, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
NIHR Newcastle Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS Trust and Newcastle University, Newcastle upon Tyne, United Kingdom.

Michiel van der Flier (M)

Section of Paediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Center for Infectious Diseases, Radboud Institute for Molecular Life Sciences, RadboudUMC, Nijmegen, the Netherlands.
Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands.

Ronald de Groot (R)

Section of Paediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Center for Infectious Diseases, Radboud Institute for Molecular Life Sciences, RadboudUMC, Nijmegen, the Netherlands.

Jethro Herberg (J)

Section of Paediatric Infectious Diseases, Imperial College, London, United Kingdom.

Benno Kohlmaier (B)

Department of General Paediatrics, Medical University of Graz, Graz, Austria.

Michael Levin (M)

Section of Paediatric Infectious Diseases, Imperial College, London, United Kingdom.

Emma Lim (E)

Great North Children's Hospital, Paediatric Immunology, Infectious Diseases & Allergy, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
NIHR Newcastle Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS Trust and Newcastle University, Newcastle upon Tyne, United Kingdom.

Ian K Maconochie (IK)

Paediatric Emergency Medicine, Imperial College Healthcare Trust NHS, London, United Kingdom.

Federico Martinon-Torres (F)

Genetics, Vaccines, Infections and Paediatrics Research group (GENVIP), Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.

Ruud G Nijman (RG)

Section of Paediatric Infectious Diseases, Imperial College, London, United Kingdom.

Marko Pokorn (M)

Department of Infectious Diseases and Faculty of Medicine, University Medical Centre Ljubljana, University of Ljubljana, Ljubljana, Slovenia.

Irene Rivero-Calle (I)

Genetics, Vaccines, Infections and Paediatrics Research group (GENVIP), Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.

Franc Strle (F)

Department of Infectious Diseases and Faculty of Medicine, University Medical Centre Ljubljana, University of Ljubljana, Ljubljana, Slovenia.

Maria Tsolia (M)

Second Department of Paediatrics, P. and A. Kyriakou Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Clementien L Vermont (CL)

Department of Paediatric Infectious diseases and Immunology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.

Shunmay Yeung (S)

Faculty of Tropical and Infectious Disease, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Joany M Zachariasse (JM)

From the Department of General Paediatrics, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.

Werner Zenz (W)

Department of General Paediatrics, Medical University of Graz, Graz, Austria.

Dace Zavadska (D)

Rīgas Stradiņa universitāte, Department of Paediatrics, Children Clinical University Hospital, Riga, Latvia.

Henriette A Moll (HA)

From the Department of General Paediatrics, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH